An early study verified that the upregulation of TSG101 might boost carcinogenesis in papillary thyroid carcinoma [21], followed by a study that proved that its expression might be necessary for processes involved in tumor progression [20]. This evidence concerns the gene TSG101 and thyroid gland papillary carcinoma.